Variable | Overall survival | |||
---|---|---|---|---|
Univariate analysis | Multivariate analysis | |||
HR (95% CI) | P value | HR (95% CI) | P value | |
Age (≥55 years old vs < 55 years old) | 1.247 (0.673–2.310) | 0.483 |  |  |
AFPa (≥400ng/ml vs < 400 ng/ml) | 1.858 (1.014–3.404) | 0.045* | 1.940 (1.008–3.735) | 0.047* |
Ascites (Have vs None) | 2.15 (1.171–3.948) | 0.014* |  | 0.067 |
ECOG PSb (0–1 vs. 2) | 2.414 (1.230–4.740) | 0.008* | 2.574 (1.278–5.185) | 0.008* |
Child-Pugh grade (A vs B) | 2.114 (1.061–4.214) | 0.033* | 2.913 (1.385–6.123) | 0.005* |
Arterioportal fistula (Have vs None) | 1.036 (0.555–1.931) | 0.912 |  |  |
Hemihepatic HCCc (Yes vs. No) | 0.454 (0.247–0.835) | 0.011* | 0.517 (0.269–0.992) | 0.047* |
HCCc diameter (>10cm vs. ≤ 10 cm) | 1.454 (0.802–2.636) | 0.218 |  |  |
Number of tumors (Single vs. Multiple) | 0.327 (0.100–1.260) | 0.065 |  |  |
Distant metastasis (Yes vs. No) | 1.829 (0.955–3.502) | 0.069 |  |  |
Hepatic vein tumor thrombosis (Yes vs. No) | 1.844 (0.850–4.003) | 0.122 |  |  |
Cavernous transformation collateral (Yes vs. No) | 0.703 (0.387–1.275) | 0.246 |  |  |
PVTTd type (III vs. IV) | 0.801 (0.371–1.731) | 0.573 |  |  |